Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,858,593 | 1,256,000 | 2,223,000 | 2,833,000 | 2,590,000 |
| Marketable Securities | 63,175 | 200,000 | 191,000 | 149,000 | 175,000 |
| Receivables | 5,027,636 | 4,308,000 | 3,629,000 | 3,352,000 | 3,312,000 |
| Inventories | 2,184,692 | 1,982,000 | 1,647,000 | 1,311,000 | 1,255,000 |
| Other current assets | 250,595 | 263,000 | 222,000 | 249,000 | 236,000 |
| TOTAL | $9,384,691 | $8,009,000 | $7,912,000 | $7,894,000 | $7,568,000 |
| Non-Current Assets | |||||
| PPE Net | 2,365,598 | 2,193,000 | 1,945,000 | 2,154,000 | 2,205,000 |
| Investments And Advances | 1,046,714 | 835,000 | 824,000 | 831,000 | 835,000 |
| Intangibles | 9,491,506 | 10,259,000 | 12,401,000 | 6,698,000 | 7,594,000 |
| Other Non-Current Assets | 1,253,972 | 968,000 | 558,000 | 892,000 | 915,000 |
| TOTAL | $14,157,790 | $14,255,000 | $15,728,000 | $10,575,000 | $11,549,000 |
| Total Assets | $23,542,480 | $22,264,000 | $23,640,000 | $18,470,000 | $19,118,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,623,283 | 1,777,000 | 3,128,000 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,318,363 | 1,252,000 | 1,226,000 | 1,054,000 | 1,072,000 |
| Other current liabilities | 1,708,496 | 3,683,000 | 3,259,000 | 3,011,000 | 2,782,000 |
| TOTAL | $8,041,447 | $7,077,000 | $8,515,000 | $5,459,000 | $5,635,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,112,000 | 3,766,000 | 2,965,000 | N/A | N/A |
| Other Non-Current Liabilities | 1,296,517 | 1,297,000 | 1,250,000 | 1,628,000 | 1,467,000 |
| TOTAL | $3,417,196 | $5,099,000 | $4,555,000 | $1,673,000 | $1,515,000 |
| Total Liabilities | $11,458,640 | $12,175,000 | $13,070,000 | $7,132,000 | $7,148,000 |
| Shareholders' Equity | |||||
| Common Shares | 679,807 | 687,000 | 682,000 | 774,000 | 844,000 |
| Retained earnings | 5,958,718 | 4,940,000 | 5,360,000 | 6,828,000 | 7,740,000 |
| Other shareholders' equity | 4,454,236 | 3,476,000 | 3,532,000 | 2,562,000 | 2,029,000 |
| TOTAL | $12,083,830 | $10,088,000 | $10,569,000 | $11,338,000 | $11,970,000 |
| Total Liabilities And Equity | $23,542,470 | $22,263,000 | $23,639,000 | $18,470,000 | $19,118,000 |